New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
09:20 EDTMX, KTOS, HDY, PRMW, PAY, EXXI, EPL, FCEL, SNTA, GERN, RAD, QIWI, OXGN, EXPROn The Fly: Pre-market Movers
UP AFTER EARNINGS: VeriFone (PAY), up 8.5%... Primo Water (PRMW), up 8.3%... QIWI (QIWI), up 2.5%. ALSO HIGHER: Oxigene (OXGN), up 128% following results from its Phase 2 clinical trial evaluating Avastin with or without ZYBRESTAT to treat patients with recurrent ovarian cancer... Rite Aid (RAD), up 3% following upgrade at Goldman... EPL Oil & Gas (EPL), up 28.8% after Energy XXI (EXXI) to acquire the company for $2.3B. DOWN AFTER EARNINGS: Express (EXPR), down 13%... Kratos Defense (KTOS), down 10%. ALSO LOWER: Hyperdynamics (HDY), down 59% after U.S. Department of Justice and the SEC to open investigations into the activities of the company... Geron (GERN), down 61% after announcing IND clinical hold affecting trials of imetelstat... Synta Pharmaceuticals (SNTA), down 16.7% after downgraded at Stifel, BMO Capital... FuelCell (FCEL), down 3.6% following downgrade at Cowen... MagnaChip (MX), down 10.7% after announcing it will restate prior financial statements... Northwest Biotherapeutics (NWBO), down 6.8% following downgrade at Oppenheimer.
News For EXPR;OXGN;QIWI;RAD;GERN;SNTA;FCEL;EPL;EXXI;PAY;PRMW;HDY;KTOS;MX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 13, 2014
10:08 EDTRADOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:47 EDTRADRite Aid initiated with a Market Perform at Cowen
Subscribe for More Information
07:12 EDTKTOSKratos Defense receives $2.1M in rail systems, mass transportation contracts
Kratos Defense announced that its Public Safety & Security Solutions Division has recently received $2.1M in new contract awards for security system deployments for certain of the United States' most important rail system and mass transportation assets. Under the new contract awards, KPSS will design, engineer, deploy and integrate into command and control infrastructure specialized security systems for the protection of these unique assets. Due to customer related and other considerations, no additional information will be provided related to these recent contract awards.
October 10, 2014
14:23 EDTEXXIEnergy XXI volatility increases as shares trend to five-year low
Energy XXI October call option implied volatility is at 101, November is at 85, December is at 98, January is at 86; compared to its 26-week average of 43 according to Track Data, suggesting large price movement.
12:11 EDTEXXIOptions with increasing implied volatility
Subscribe for More Information
09:17 EDTPAYVeriFone management to meet with Deutsche Bank
Subscribe for More Information
07:14 EDTPAYJackson Square reports 11.94% passive stake in VeriFone
October 9, 2014
11:00 EDTEXXIOptions with increasing implied volatility
Options with increasing implied volatility: ARWR PBR EXXI PWE GST GLNG WTW AFSI ETE VALE
10:50 EDTEXPRGap falls after announcing CEO Murphy will step down, weak September sales
Subscribe for More Information
09:41 EDTEXPRBofA/Merrill retail analysts hold an analyst/industry conference call
Subscribe for More Information
07:08 EDTKTOSKratos Defense awarded $2.2M contract by U.S. Navy
Subscribe for More Information
October 8, 2014
12:49 EDTKTOSKratos Defense has large upside potential, Barron's reports
Subscribe for More Information
09:11 EDTFCELFuelCell management to meet with UBS
Subscribe for More Information
October 7, 2014
16:03 EDTOXGNOXiGENE announces first patient enrolled in phase 1b/2 study of Fosbretabulin
OXiGENE announced that the first patient has been enrolled in a phase 1b/2 clinical study that will evaluate fosbretabulin in combination with Votrient in patients with recurrent ovarian cancer. The randomized, controlled clinical study consists of a phase 1b dose escalation portion with the combination of fosbretabulin and pazopanib and a phase 2 portion comparing fosbretabulin and pazopanib versus pazopanib alone. The study is estimated to enroll up to 128 patients at sites in the United Kingdom. The primary endpoint is progression-free survival, and secondary endpoints include safety, overall survival, objective response rate and relevant biomarkers.
16:01 EDTKTOSKratos Defense receives $8.5M airborne communications system contract
Subscribe for More Information
10:02 EDTPAYOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:36 EDTFCELFuelCell awarded contract to evaluate DFC power plants
Subscribe for More Information
08:03 EDTPAYVeriFone, Sunoco forge agreement to install integrated dispenser video screens
VeriFone Systems (PAY) and Sunoco (SUN) announced that VeriFone has been selected as the exclusive media provider for Sunoco’s fueling islands. VeriFone will provide Sunoco with dispenser card readers that have integrated video screens and dynamic streaming content. These payment terminals will enhance the fueling experience for Sunoco’s customers and provide a cost-efficient EMV strategy for Sunoco’s growing network of branded retailers.
06:09 EDTMXMagnaChip announces NYSE listing extension
Subscribe for More Information
05:34 EDTPAYVeriFone initiated with an Outperform at Pacific Crest
Target $39.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use